Geneos Wealth Management Inc. Humacyte, Inc. Transaction History
Geneos Wealth Management Inc.
- $3.85 Billion
- Q4 2025
A detailed history of Geneos Wealth Management Inc. transactions in Humacyte, Inc. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 2,000 shares of HUMA stock, worth $2,360. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000Holding current value
$2,360% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HUMA
# of Institutions
159Shares Held
45MCall Options Held
383KPut Options Held
490K-
Vanguard Group Inc Valley Forge, PA8.42MShares$9.93 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.14MShares$8.43 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.1MShares$3.65 Million0.0% of portfolio
-
Ubs Group Ag2.98MShares$3.51 Million0.0% of portfolio
-
State Street Corp Boston, MA2.41MShares$2.84 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $122M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...